Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Anthelmintic |
Is a |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antiprotozoal |
Is a |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medicinal product containing biguanide and acting as antimalarial agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing antimony compound and antiprotozoal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dichloroacetamide and antiprotozoal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydroxyquinoline and antiprotozoal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amebicide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antileishmanial drug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing antitrichomonal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antischistosomal drug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing anthelmintic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing antimalarial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antiprotozoal drug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antiparasite drug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing antibabesial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Drugs for trichomonacides |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antigiardial drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atebrine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trypanocides[no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Drugs for toxoplasmosis [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Drugs for threadworms |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Anthelmintics - anticestodals |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Drugs for hookworms |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Schistosomicides [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Drugs for guinea worms [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Drugs for strongyloidiasis |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Drugs for pneumocystis pneumonia |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paromomycin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing artemether and lumefantrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Artemether+lumefantrine 20mg/120mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide- and potassium hydroxyquinoline sulfate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide+potassium hydroxyquinoline sulfate 10/0.5% cream (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide+potassium hydroxyquinoline sulfate 5/0.5% lotio-gel (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely benzoyl peroxide 50 milligram/1 gram and potassium hydroxyquinoline sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing potassium hydroxyquinoline sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing amebicide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parasiticidal preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Artemisinin antimalarial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Artemether 20 mg and lumefantrine 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfiram |
Is a |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzyl benzoate (substance) |
Is a |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paromomycin |
Is a |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fipronil |
Is a |
False |
agent antiparasitaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|